Deeming Rule

February 12, 2026

Highly purified cannabidiol (CBD) in CDKL5 deficiency disorder (CDD): Open‐label prospective study

Abstract Objective: CDKL5 deficiency disorder (CDD) is an early‐onset developmental and epileptic encephalopathy characterized by frequent drug‐resistant seizures, cerebral visual…

October 30, 2025

Real‐world efficacy and safety of cannabidiol in developmental and epileptic encephalopathies

Abstract Objective: Highly purified cannabidiol (CBD) is approved as adjunctive therapy for seizures associated with Dravet syndrome (DS), Lennox–Gastaut syndrome…

November 28, 2022

An Assessment of Vape Shop Products in California before and after Implementation of FDA and State Regulations

Abstract Vape shops specialize in sales of e-cigarettes and related products. This study examines whether vape shops adapted their products…